Ergoteles LLC Agenus Inc Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.31 - $2.04 $316,627 - $493,068
241,700 New
241,700 $386,000
Q4 2022

Feb 14, 2023
SELL
$2.02 - $3.25 $239,509 - $385,349
-118,569 Reduced 84.03%
22,531 $54,000
Q3 2022

Nov 14, 2022
BUY
$1.96 - $3.14 $276,556 - $443,054
141,100 New
141,100 $289,000
Q4 2021

Feb 14, 2022
SELL
$2.92 - $5.74 $782,256 - $1.54 Million
-267,896 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$4.98 - $6.63 $1.33 Million - $1.78 Million
267,896 New
267,896 $1.41 Million

Others Institutions Holding AGEN

# of Institutions
9
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email